.png)
Peptides are one of the most talked-about and most misrepresented categories in modern medicine. In this episode, we cut through the noise and lay out what peptides actually are, how they work in the body, and the categories most relevant in clinical practice today. From GLP-1s and growth hormone peptides to healing, cosmetic, and immune-modulating peptides, we cover the proposed mechanisms, the human data, what is and isn't FDA approved, and the safety questions every patient should ask before starting one.
This is meant to be what social media cannot: the framework you need to make a thoughtful, informed decision​​​
​
​
​
​​​Key Takeaways
​​​​​
-
00:06 — Introduction to peptides and why the conversation deserves clarity
-
00:38 — Understanding peptides: the basics and how they function in the body
-
01:58 — Peptides in modern medicine: applications and limitations
-
02:50 — Categories 1 and 2: metabolic peptides and growth hormone-releasing peptides
-
05:07 — Category 3: healing and regenerative peptides
-
07:04 — Category 4: cosmetic and skin peptides
-
08:24 — Category 5: immune-modulating peptides
-
08:49 — Safety, sourcing, and how peptides are regulated
-
11:14 — Making informed decisions about peptide therapy
​​​
References
Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discovery Today. 2015.
Lee AC et al. Peptide therapeutics: progress and challenges. Drug Discovery Today. 2019.
Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. NEJM. 2021.
DOI: 10.1056/NEJMoa2032183
Sikiric P et al. Stable gastric pentadecapeptide BPC-157. Current Pharmaceutical Design. 2018.
Lau JL, Dunn MK. Therapeutic peptides: historical perspectives. Bioorganic & Medicinal Chemistry. 2018.
DOI: 10.1016/j.bmc.2017.06.05
​​​
Follow us
​
TikTok
Medical Providers Join my Clinician Education Platform
​​​
Full Transcript​
Why Peptides Deserve a Clearer Conversation
​
Peptides are everywhere. They are all over social media, and patients are asking about them daily. As a provider who believes in the future of peptide therapy, my priority is your safety. In this episode, we will walk through what peptides actually are, the categories that matter, the questions you should ask before starting one, and the data that can help you decide whether peptides belong in your protocol.
​
What Peptides Actually Are
​
Peptides are short chains of amino acids, the same building blocks that, in longer chains, form proteins. Imagine amino acids as Lego pieces. Individually, they are just pieces. Linked in small groups, they form peptides. Linked in longer chains, they form proteins.
​
Your body naturally produces thousands of peptides. Some of the most familiar include:
-
Insulin, which regulates blood sugar
-
Glucagon, which raises blood sugar when needed
-
Oxytocin, which supports bonding and childbirth
-
Growth hormone-releasing hormone, which prompts the release of growth hormone
​
Peptides function as biological signaling molecules. They regulate metabolism, inflammation, tissue repair, immune function, and hormone production. That signaling capacity is what makes them so clinically interesting.
​
Why Peptides Matter in Modern Medicine
Peptides are not new. Insulin, one of the most consequential medications in modern history, is a peptide discovered in the 1920s. Today, more than eighty peptide drugs are approved globally, with hundreds more in clinical development.
​
They are used to treat diabetes, osteoporosis, infertility, cancer, hormone deficiencies, and a growing list of other conditions. Their appeal in medicine is that they often target specific receptors, mimic natural biological signals, and produce fewer systemic side effects than broader pharmacologic interventions.
​
Their limitations are equally important. Peptides break down quickly in the digestive tract, which means most cannot be taken orally. They must be administered by subcutaneous injection, nasal spray, or topical application. They can be expensive, and many are still considered experimental with limited long-term human data.
​
Category 1: Metabolic Peptides
Metabolic peptides help regulate glucose, appetite, and metabolism. This category includes some of the most researched and FDA-approved peptides on the market. Common examples include:
​
-
Semaglutide
-
Tirzepatide
-
Liraglutide
-
GIP-based peptides
​
These medications work by increasing insulin secretion, slowing gastric emptying, and reducing appetite. They act in both the gut and the brain. Some clinical studies have shown 10 to 20 percent decreases in body weight in the right patient populations.
​
The question I always come back to with patients is not whether a peptide works, but whether it is the right tool for the individual. Metabolic peptides are clinically well-supported for patients with obesity, insulin resistance, or type 2 diabetes. They are not a general shortcut for weight loss without underlying metabolic context.
​
Category 2: Growth Hormone-Releasing Peptides
​
These peptides stimulate the body to produce its own growth hormone rather than delivering growth hormone directly. Examples include:
​
-
CJC-1295
-
Ipamorelin
-
Sermorelin (formerly FDA approved)
-
Tesamorelin (currently FDA approved for HIV-related lipodystrophy)
​
They are used clinically to support muscle growth, fat metabolism, tissue repair, sleep, and recovery. Most of these peptides are not FDA approved and are used off-label, with tesamorelin being the notable exception in a specific patient population.
​
Theoretical risks: Because these peptides signal the body to grow, there is a theoretical concern about promoting the growth of undesired tissues, including cancers. Patient selection matters. So does clinical monitoring, particularly IGF-1 levels.
​
Category 3: Healing and Regenerative Peptides
​
This category includes peptides used for tissue repair, wound healing, and inflammation modulation. The most-discussed examples are:
​
-
BPC-157, a peptide derived from gastric secretions. Animal research supports its role in tendon healing, muscle repair, and gut protection.
-
TB-500 (thymosin beta-4), which supports tissue repair, cell migration, and wound healing.
​
The combination of BPC-157 and TB-500 has become popularly known as the "Wolverine stack" and is used by some orthopedic and integrative providers to support post-surgical recovery and musculoskeletal injuries.
​
Theoretical risks: These peptides promote new blood vessel formation and cellular proliferation. In patients with a history of cancer or significant cancer risk, this raises concerns worth discussing with a clinician. Human data is still limited, and much of what we currently know comes from animal research.
​
Category 4: Skin and Cosmetic Peptides
​
Peptides used in dermatology and skincare fall into this category. The most-discussed include:
​
-
Matrixyl and tetrapeptide-7, which support collagen production, elastin formation, and wound healing
-
Argireline, sometimes called a topical Botox alternative, which supports muscle relaxation at the surface level
-
GHK-Cu, one of the most studied topical peptides for skin repair, elasticity, wrinkle reduction, and wound healing
​
Human research on GHK-Cu is topical. There are no human studies on injectable GHK-Cu, which is an important distinction to raise with any provider offering it that way. Patients using GHK-Cu should also have their copper and zinc levels monitored, since these two nutrients interact and can be affected by each other.
​
Category 5: Immune-Modulating Peptides
​
These peptides influence how the immune system signals and responds. The most studied example is:
​
-
Thymosin alpha-1, which has been researched for viral infections, immune support, and as an adjunctive therapy in cancer treatment. It has also been investigated in hepatitis and COVID-19-related immune modulation.
​
This category is smaller and more targeted, and most appropriate under specific clinical circumstances rather than as general wellness support.
​
The Safety Conversation
​
This is the part of the episode I want to make sure lands clearly. Peptide safety depends heavily on sourcing.
FDA-approved peptides (insulin, GLP-1 medications, calcitonin, tesamorelin, SS-31, and others) are produced under strict regulatory oversight. They represent the most rigorously studied end of the spectrum.
​
Not FDA-approved does not automatically mean unsafe. Many clinically appropriate peptides are compounded by licensed pharmacies operating under strict standards. What matters is where the peptide comes from, how it is prepared, and whether it can be verified.
​
Compounded Peptides Versus Research Chemicals
​
Compounded peptides are prepared by licensed compounding pharmacies operating under USP standards and either state board of pharmacy oversight (503A) or FDA oversight (503B). Reputable compounding pharmacies can provide certificates of analysis, use ingredients with verified purity, and follow documented protocols for each preparation.
​
Investigational compounds are peptides being studied in clinical trials that have not yet reached FDA approval.
Research chemicals are a completely different category. These are peptides sold online by unregulated vendors, labeled "for research use only," with no medical oversight, no certificate of analysis, no third-party testing, and no enforceable standards for identity, purity, or sterility. The label is precisely what it says: not for use in humans.
The growing trend of patients sourcing peptides from research chemical vendors is one of the most concerning developments in this space. A peptide is only as safe as the compound being injected.
​
Questions to Ask Before Starting a Peptide
​
-
Is this peptide FDA approved?
-
If not, is it being prepared by a licensed compounding pharmacy?
-
Is the pharmacy 503A or 503B?
-
Is a certificate of analysis available for this specific batch?
-
Is the active ingredient third-party tested?
-
What is the prescribing clinician's experience with this specific peptide?
-
What are the theoretical risks, and how will they be monitored?
-
Are there conditions in my history that make this peptide inadvisable?
​
If these questions cannot be answered clearly, the peptide is not ready to be started.
​
Who May Genuinely Benefit
​
Peptide therapy is most appropriate when matched thoughtfully to clinical context:
​
-
Patients with metabolic dysfunction, insulin resistance, type 2 diabetes, or obesity may benefit from GLP-1 therapy.
-
Patients recovering from injury, surgery, or musculoskeletal conditions may benefit from healing peptides, with appropriate oversight.
-
Patients with skin concerns, scars, or post-procedural recovery needs may benefit from topical cosmetic peptides.
-
Patients with immune dysregulation, certain viral conditions, or adjunctive needs in cancer care may benefit from immune-modulating peptides.
​
The category of longevity and anti-aging remains the most speculative. Many peptides marketed for this purpose have promising mechanisms but insufficient human data. The honest clinical position is that we do not yet know enough, and that uncertainty is a reason to proceed thoughtfully, not to make sweeping claims in either direction.
​
Peptides Don't Replace the Basics
​
Peptides are signaling molecules. They amplify the systems they interact with, but they do not replace the lifestyle work those systems depend on.
​
-
A GLP-1 will not undo a diet built around ultra-processed foods.
-
A growth hormone peptide will not build muscle in the absence of resistance training and adequate protein.
-
A healing peptide will not regenerate tissue that isn't being supported by sleep, nutrition, and stress management.
​
Peptides are one piece of the puzzle. Sometimes a meaningful one. Never the whole picture.
​
Final Takeaways
​
Peptide therapy is real, evolving, and clinically significant. It is also a space where marketing has moved faster than education, and where the gap between what is safe and what is being sold has widened in ways that put patients at risk.
​
If you are considering peptides, ask the right questions. Work with clinicians who answer them honestly. Source carefully. Monitor thoughtfully. And remember that no signaling molecule replaces the daily work of taking care of the body it is signaling to.
​
Peptides can be powerful. They should be used like anything powerful: with intention, with oversight, and with a clear answer to the most important question. Why am I using this, and is it the right tool for me?
​​​
FAQs​
How are peptides administered?
Because peptides break down quickly in the digestive tract, most are administered by subcutaneous injection or nasal spray rather than oral capsules. Some skin and cosmetic peptides are applied topically.
​
Are peptides safe?
Reputable, properly sourced peptides used under appropriate clinical oversight are generally well-tolerated. Safety depends heavily on sourcing, purity, dosing, and patient selection. Peptides sourced from unregulated online vendors marketed "for research use only" are not safe for human use, regardless of how they are framed.
What is the difference between compounded peptides and research chemicals?
Compounded peptides are prepared by licensed compounding pharmacies under USP standards and state or FDA regulatory oversight, with traceable sourcing and certificates of analysis. Research chemicals are sold by unregulated online vendors without medical oversight, third-party testing, or quality assurance, and are not intended for human use.
​
Do peptides help with aging or longevity?
The category of longevity peptides is one of the most speculative areas of peptide therapy. Several peptides have promising mechanisms, but human data is insufficient to make confident long-term claims. The honest position is that we do not yet know enough to recommend them broadly for this purpose.
​
Do peptides cause cancer?
Most peptides do not. However, peptides that promote growth, including growth hormone-releasing peptides and some healing peptides, carry a theoretical concern in patients with active or recent cancer or significant familial cancer risk. Patient selection and clinical monitoring are important in this context.
​
Can I take peptides as a pill?
Most peptides cannot be taken orally because they are broken down by digestive enzymes before they can be absorbed. Most clinically relevant peptides are administered by injection, nasal spray, or topical application.
Should I monitor anything while on peptide therapy?
Yes. Monitoring depends on the peptide. Patients on GLP-1 therapy may have metabolic markers and weight tracked. Patients on growth hormone-releasing peptides may have IGF-1 levels checked. Patients on GHK-Cu should have copper and zinc levels monitored. Monitoring should be tailored to the peptide and the patient and overseen by a qualified clinician.
​
Do peptides replace lifestyle changes?
No. Peptides amplify the systems they interact with but do not replace the lifestyle foundation those systems depend on. They work best as part of a broader plan that includes nutrition, movement, sleep, stress management, and appropriate medical care.
​
Terms used:​
1. Blood glucose - the main sugar found in your blood, derived from food and serving as the body's primary energy source
2. Insulin - a vital hormone produced by the pancreas that regulates blood sugar (glucose) levels by allowing cells to take in glucose for energy
3. Semaglutide - a prescription medication (GLP-1 receptor agonist) used to treat type 2 diabetes, manage long-term weight loss, and reduce cardiovascular risks
4. Tirzepatide - a once-weekly, subcutaneous medication approved for treating type 2 diabetes (brand name Mounjaro) and for chronic weight management (brand name Zepbound)
5. Sermorelin - a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release natural human growth hormone (hGH)
6. Tesamorelin - a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release natural human growth hormone (hGH)
7. HIV - Human Immunodeficiency Virus; a virus that attacks the body's immune system
8. Gastric secretion - essential fluids produced by the gastric mucosa, totaling 1.2 to 1.5 liters daily, comprising hydrochloric acid (HCl), pepsinogen, mucus, and intrinsic factor
9. Elastin - a highly elastic protein found in connective tissue, allowing skin, lungs, and blood vessels to stretch and snap back into place
10. Neuromodulator - substances that regulate diverse populations of neurons, altering their activity over longer periods than neurotransmitters
11. Investigational compound - a substance undergoing clinical trials to evaluate its safety and efficacy in humans, having passed preclinical laboratory/animal testing but lacking FDA approval for general marketing